Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

Indian pharma

  1. Home>
  2. News>
  3. Indian pharma>
  4. Page 5

Indian Pharma’s $19.1B US Push Amid Generics Tariff Exemption

  • Post published:June 20, 2026
  • Post category:News

🇺🇸 US Imposes 100% Tariff on Patented Drug Imports from India In a major trade policy shift, the United States imposed a 100% tariff on patented pharmaceutical products imported from…

Continue Reading Indian Pharma’s $19.1B US Push Amid Generics Tariff Exemption

How to Verify Indian Generic Medicine Quality: A Practical Checklist for International Buyers

  • Post published:June 18, 2026
  • Post category:Knowledge

📋 Why Verification Matters When Sourcing from India India supplies over 20% of the world's generic medicines by volume (GTRI, May 2026) and 60% of global vaccine demand. For international…

Continue Reading How to Verify Indian Generic Medicine Quality: A Practical Checklist for International Buyers

How to Safely Import Generic Medicines from India: A 2026 Buyer’s Guide

  • Post published:June 17, 2026
  • Post category:Knowledge

How to Safely Import Generic Medicines from India: A 2026 Buyer's Guide India supplies over 20% of the world's generic medicines by volume and 60% of global vaccine demand. For…

Continue Reading How to Safely Import Generic Medicines from India: A 2026 Buyer’s Guide

India’s Generic Semaglutide Boom Reshapes Global GLP-1 Market

  • Post published:June 15, 2026
  • Post category:News

Indian generic drugmakers have launched a wave of affordable semaglutide products following the expiry of Novo Nordisk's key patents, with over 50 brands expected in the coming months and prices…

Continue Reading India’s Generic Semaglutide Boom Reshapes Global GLP-1 Market
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Go to the next page

Recent Posts

  • India Pharma July 2026: CETA Effect, FDA Filings Lead, Market Grows 16%
    July 14, 2026/
    0 Comments
  • Understanding WHO Prequalification for Indian Generic Medicines: A Buyer’s Guide
    July 5, 2026/
    0 Comments
  • Indian Pharma Exports Rise 6.6%: Nifty Pharma Hits Record High in 2026
    July 4, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • India Pharma July 2026: CETA Effect, FDA Filings Lead, Market Grows 16%
  • Understanding WHO Prequalification for Indian Generic Medicines: A Buyer’s Guide
  • Indian Pharma Exports Rise 6.6%: Nifty Pharma Hits Record High in 2026
  • India’s Generic Drug Quality Revolution: Schedule M and CDSCO Audit Guide 2026
  • India Pharma Mid-2026: FDA Filings Lead China, API Prices Drop, Biosimilars Rise

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve